Dashboard
1
Poor long term growth as Operating profit has grown by an annual rate 2.19% of over the last 5 years
2
The company declared positive results in Dec'24 after very negative results in Sep'24
3
With ROE of 2.31%, it has a very attractive valuation with a 0.18 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
VND 144,585 Million (Micro Cap)
8.00
NA
4.76%
0.12
2.31%
0.18
Revenue and Profits:
Net Sales:
82,515 Million
(Quarterly Results - Mar 2025)
Net Profit:
3,149 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.78%
0%
-2.78%
6 Months
-7.49%
0%
-7.49%
1 Year
-7.08%
0%
-7.08%
2 Years
-4.55%
0%
-4.55%
3 Years
-29.05%
0%
-29.05%
4 Years
-48.78%
0%
-48.78%
5 Years
-20.45%
0%
-20.45%
SPM Corp. (Vietnam) for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-10.91%
EBIT Growth (5y)
2.19%
EBIT to Interest (avg)
3.04
Debt to EBITDA (avg)
4.34
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.41
Tax Ratio
11.23%
Dividend Payout Ratio
149.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.32%
ROE (avg)
2.02%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.18
EV to EBIT
8.28
EV to EBITDA
4.94
EV to Capital Employed
0.27
EV to Sales
0.81
PEG Ratio
0.08
Dividend Yield
4.76%
ROCE (Latest)
3.22%
ROE (Latest)
2.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
82,515.40
73,157.70
12.79%
Operating Profit (PBDIT) excl Other Income
10,666.90
16,207.80
-34.19%
Interest
1,575.00
1,726.70
-8.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,148.60
10,166.60
-69.03%
Operating Profit Margin (Excl OI)
69.30%
155.00%
-8.57%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is 12.79% vs -0.71% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is -69.03% vs 730.47% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
297,775.00
406,104.90
-26.68%
Operating Profit (PBDIT) excl Other Income
28,068.80
42,470.20
-33.91%
Interest
7,446.80
11,761.30
-36.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,618.20
12,116.70
-61.89%
Operating Profit Margin (Excl OI)
38.20%
75.10%
-3.69%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -26.68% vs -41.76% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -61.89% vs -49.29% in Dec 2023
About SPM Corp. (Vietnam) 
SPM Corp. (Vietnam)
Pharmaceuticals & Biotechnology
S.P.M Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and imports multivitamin and mineral supplements, tonic and natural products, functional food, as well as various other kinds of drugs. It is engaged in the trading of drugs to domestic market and overseas markets, such as the United States, Myanmar and Malaysia. Its products are distributed solely by Do Thanh Pharmaceutical Company Limited. The Company also trades medical equipment and supplies. In addition, it provides offices, spaces and warehouses for rent.
Company Coordinates 
Company Details
Lo 51, Duong so 2, KCN Tan Tao, Q. Binh Tan HO CHI MINH None : None
Registrar Details






